Nitroglycerin Streuli

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Nitroglycerin Streuli

What is Nitroglycerin Streuli? Definition and Type

Property Description
Active ingredient Glyceryl Trinitrate (Nitroglycerin)
Form Sublingual tablet or Oral spray
Pharmacological class Organic Nitrate, Vasodilator
General Purpose Rapid relief of Angina Pectoris
Origin Streuli Pharma (Switzerland)

Nitroglycerin Streuli is a specific pharmaceutical brand containing the active substance Glyceryl Trinitrate (GTN), commonly known as Nitroglycerin. It is a synthetic compound manufactured by Streuli Pharma in Switzerland, primarily utilized for cardiovascular treatment. This formulation is typically supplied as a sublingual tablet or a metered-dose oral spray, designed for rapid absorption.

This rapid-acting nature is clinically recognized for providing swift symptomatic relief during acute cardiac events, differentiating it from slow-release maintenance medications.


Composition and Pharmacological Class

The core component of the medicine is Glyceryl Trinitrate. It is categorized within the pharmacological class of organic nitrates and functions as a powerful vasodilator. This classification is key to its effect, as vasodilators promote the widening and relaxation of blood vessels.

This medication is a Prescription-Only Medicine (Rx) in many regions due to the serious nature of the conditions it is designed to manage. Its mechanism relies on its conversion into nitric oxide, a natural signaling molecule that relaxes vascular smooth muscle.


General Therapeutic Purpose

The general therapeutic purpose of Nitroglycerin Streuli is the rapid relief of acute episodes of angina pectoris (chest pain). It is specifically intended for intervention during sudden attacks of chest discomfort caused by insufficient oxygen supply to the heart muscle.

Additionally, it is used for acute prophylaxis, meaning a patient may take it preventatively immediately before engaging in activities that are known to reliably trigger anginal symptoms. It functions as an essential short-term tool for symptom management, rather than a long-term treatment for underlying coronary artery disease.

What side effects are possible with Nitroglycerin Streuli?

Possible Side Effects and Safety Information

The safety profile of Nitroglycerin (Glyceryl Trinitrate) is based on its primary action as a powerful vasodilator, with adverse reactions organized by regulatory authorities (such as the FDA and EMA) into frequency and system-organ classifications.


Documented Adverse Reactions

The most commonly reported adverse effect is headache, which is officially categorized as very common. This effect is often noted as being most pronounced at the start of therapy and may lessen with continued use. Other common adverse reactions are primarily related to the circulatory system, including dizziness, hypotension (low blood pressure, particularly orthostatic hypotension), facial flushing, and tachycardia (increased heart rate).

System-Organ Class Common Adverse Reactions
Nervous System Headache, Dizziness
Vascular Hypotension, Facial Flushing
Cardiac Tachycardia

Serious Adverse Reactions and Restrictions

Official labeling documents serious adverse reactions such as severe hypotension that may lead to syncope (fainting) or circulatory collapse. Reflex bradycardia (unusually slow heart rate) can also occur. A critical, non-negotiable safety restriction is the absolute contraindication against concurrent use with PDE-5 inhibitors (such as sildenafil or tadalafil) due to the risk of life-threatening, profound hypotension.

Safety constraints also apply to certain medical conditions, including severe anemia, conditions associated with increased intracranial pressure, and Hypertrophic Obstructive Cardiomyopathy (HOCM), where the drug's use is contraindicated or requires specific caution. Older adults may be more susceptible to the hypotensive effects.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Glyceryl Trinitrate is characterized by an exaggerated physiological response to its powerful vasodilatory properties, resulting in severe clinical signs. The primary manifestation documented in regulatory sources is profound hypotension, which can rapidly progress to circulatory failure and shock. Documented effects on the Central Nervous System include persistent throbbing headache, confusion, somnolence, and in severe instances, convulsions and coma. A specific toxicological concern is the development of Methemoglobinemia, which impairs oxygen delivery and may result in cyanosis.

Regulatory authorities mandate specific actions upon suspected overdose. The medication must be discontinued immediately. Urgent medical help is required if chest pain persists after a total of three tablets or sprays have been used within a 15-minute period.

The official protocol for management emphasizes symptomatic and supportive care, centered on correcting the hemodynamic effects. This includes immediate procedures such as elevation of the lower limbs and the administration of intravenous fluids for volume expansion. For clinically significant Methemoglobinemia, Methylene Blue is the specific therapeutic agent documented for intervention. Continuous monitoring of vital signs and cardiac function is required. Individuals who are volume-depleted or have certain enzyme deficiencies are noted as being more susceptible to severe overdose effects.

Therapeutic Uses of Nitroglycerin Streuli

What Nitroglycerin Streuli Treats: Main Uses and Benefits

Nitroglycerin Streuli is commonly used to provide supportive symptomatic relief during sudden episodes of angina pectoris. This medication is applicable in situations where symptoms cluster into patterns requiring short-term symptomatic assistance, including chest pain, tightness, and associated discomfort that may radiate to the jaw or arm, and is relevant to overall symptom management.

It is relevant for two key therapeutic applications: managing the acute symptomatic episodes themselves and for acute prophylaxis before predictable exertion. This approach helps patients cope more steadily with difficult episodes and supports the patient during episodes of heightened discomfort.

“This medication is applied in managing the challenging symptomatic manifestations of temporary myocardial ischemia.”

This medication is also relevant for acute prophylaxis, a preventative approach applied before engaging in activities that may bring on anginal symptoms, such as physical exertion or significant emotional tension. Used in these clinical settings, the medication may assist in managing the potential onset of a painful episode.

Quick Fact: Relief for Acute Angina
Use Focus: Symptomatic relief of Angina Pectoris
Use Contexts: Acute symptomatic intervention and acute prophylaxis
Patient Benefit: Contributes to easing the overall symptom load

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Nitroglycerin Streuli (Glyceryl Trinitrate) is intended for use in adults for the acute relief and prophylaxis of angina pectoris. Eligibility is strictly defined by regulatory contraindications and specific population limitations.

Contraindicated Populations (Must Not Use)

Condition / Population Restriction Type (Official Labeling)
Use of PDE-5 inhibitors (e.g., sildenafil) or sGC stimulators (e.g., riociguat) Absolute Contraindication (Risk of severe hypotension)
Known Hypersensitivity to nitrates or excipients Contraindication
Severe Anemia Contraindication
Conditions causing Increased Intracranial Pressure (e.g., cerebral hemorrhage) Contraindication
Acute Circulatory Failure or Shock Contraindication
Hypertrophic Obstructive Cardiomyopathy (HOCM) Contraindication (Aggravation risk)

Specific Eligibility Limitations

  • Pediatric Use: The safety and effectiveness have not been established in pediatric patients by regulatory authorities; therefore, use is not generally recommended in this age group.
  • Geriatric Use: Use in older adults is permitted but may require cautious dose selection, often starting at the lower end of the approved range, due to the potential for reduced renal, hepatic, or cardiac function.
  • Pregnancy and Lactation: Use during pregnancy is advised only if clearly necessary, as adequate data on drug-associated risk are limited. It is not known if the drug is excreted into human milk, leading to cautionary statements regarding lactation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The regulatory profile for Glyceryl Trinitrate establishes specific interaction constraints, focusing heavily on agents that cause additive cardiovascular effects.

Contraindicated Combinations and Timing

Co-administration with Phosphodiesterase-5 (PDE5) Inhibitors (e.g., Sildenafil, Tadalafil) and Soluble Guanylate Cyclase (sGC) Stimulators (e.g., Riociguat) is contraindicated. This formal restriction is due to the severe potentiation of hypotensive effects. Regulatory documents note that the risk is related to the half-life of the PDE5 inhibitor, with separation windows of up to 48 hours cited for some agents.

Pharmacodynamic and Exposure Interactions

Other medicinal products may cause additive hypotensive effects, including most Antihypertensives (e.g., Beta-blockers, Diuretics) and certain Tricyclic Antidepressants or Neuroleptics. A key pharmacokinetic interaction is noted with Dihydroergotamine, as nitroglycerin use markedly decreases the first-pass metabolism of the ergot alkaloid, increasing its oral bioavailability. Systemic nitrates may also weaken the anticoagulant effects of Heparin.

Other Documented Constraints

Aspirin may decrease the clearance of sublingual nitroglycerin, enhancing its hemodynamic effects. Consumption of Alcohol is noted to potentiate the blood-pressure-lowering effect. Furthermore, the effectiveness of sublingual tablets may be reduced in patients taking Anticholinergic Drugs due to regulatory warnings about impaired dissolution from dry mouth.

Mechanism of Action

How Nitroglycerin Streuli Works

Conversion to Nitric Oxide and Cellular Signaling

Nitroglycerin functions as a prodrug, undergoing rapid conversion inside vascular smooth muscle cells to release nitric oxide (NO). This NO engages the cGMP signaling pathway, activating the enzyme guanylate cyclase and resulting in an increase in the secondary messenger molecule cGMP, which ultimately triggers muscle relaxation.


Vasodilation and Modulation of Hemodynamics

The relaxation of the vascular smooth muscle caused by the cGMP cascade results in widespread vasodilation, preferentially widening the veins while also dilating the arteries. This modulation of peripheral vascular tone alters hemodynamics, resulting in a decrease in the volume of blood returning to the heart (cardiac preload) and a reduction in the resistance the heart encounters during ejection (cardiac afterload).


Reducing the Heart's Oxygen Requirement

The combined physiological effect of reduced preload and afterload decreases the mechanical workload imposed on the heart muscle. This decrease in cardiac workload directly leads to a reduced myocardial oxygen requirement, which is the final observable physiological consequence of the drug’s mechanism and is critical to the resulting physiological state.

Dosage and Administration Information

How to Use Nitroglycerin Streuli

The administration of Glyceryl Trinitrate (Nitroglycerin) acute-relief products is based on established guidelines that define the route, dosing, and frequency for acute intervention. The medication is intended for intermittent use on an as-needed (p.r.n.) basis, not as a scheduled daily treatment.


Official Administration and Dosing Protocol

The approved route of administration for Nitroglycerin Streuli in its quick-acting forms (tablets, sprays) is Sublingual (under the tongue) or Translingual (onto or under the tongue).

Standard Dosing Regimen (Acute Intervention):

Procedural Step Dose and Timing
Initial Dose One unit (e.g., a 0.4 mg tablet or spray) at the onset of symptoms.
Repeat Dosing Wait 5 minutes; if symptoms persist, administer a second unit.
Maximum Limit No more than a total of three doses should be administered within a 15-minute period.

Procedural and Contextual Constraints

The proper technique for administration is essential for the intended rapid effect. Sublingual tablets must be allowed to dissolve completely without being chewed, crushed, or swallowed. For the translingual spray, the dose must be administered onto or under the tongue, and the patient must avoid inhaling the spray. The official protocol dictates that if symptoms continue after the maximum third dose within 15 minutes, the use pattern ceases, and the patient must seek prompt medical assessment. Dosing for older adults often begins at the low end of the dosage range, though routine age-based adjustments are not standardized for this acute use.

Recent Clinical Evidence

Research Evidence / Overview of Studies


Phase 3 Trials: Symptom Relief and Patient Outcomes

Research has explored the compound's mechanism, which involves the local generation of nitric oxide (NO) that mediates smooth muscle relaxation in blood vessel walls. Studies have examined its primary role in reducing chest pain (angina) caused by insufficient blood flow to the heart muscle. Clinical trials assessed the compound's impact on pain reduction, with investigators reporting that changes in discomfort were noted rapidly following dosing, as documented in the specific trial protocols.


Long-term Tolerability and Specific Use Cases

Primary Findings from Systematic Reviews

Systematic reviews have examined the relationship between compound use and long-term symptom progression in individuals with stable angina, noting a measured change in the frequency of anginal attacks and improved exercise capacity over time. The study designs evaluated long-term tolerability, including the potential for tolerance to develop with continuous use.


Pharmacokinetic and Dosing Research

Exploring Bioavailability

Pharmacokinetic research evaluates how the body handles the compound. It observed that the sublingual route of administration allows for rapid absorption directly into the bloodstream, bypassing the initial metabolism that would occur with oral forms. This line of research also evaluated the time taken to reach peak plasma concentration, which occurs within minutes of administration.

Dose Evaluation Protocols

Research designs included evaluating varying dosage schedules to identify effective concentrations for acute relief and prophylaxis. Trial data recorded common adverse events, such as headache, and assessed participant withdrawal rates for overall tolerability analysis. Studies involving specific patient populations, such as those with pre-existing cardiovascular conditions, were limited or excluded certain groups, and caution is advised in these areas.

Frequently Asked Questions (FAQ)

Common questions about Nitroglycerin Streuli (FAQ)


Q: How quickly is Nitroglycerin Streuli supposed to start working?

Official documents and research findings describe quick-acting sublingual nitroglycerin as rapidly absorbed. Relief for symptoms is often noted within 1 to 5 minutes following administration, as the medicine is noted to reach peak concentration in the bloodstream quickly.


Q: What happens if someone accidentally uses too much Nitroglycerin Streuli?

Regulatory guidance defines a maximum limit for the acute intervention protocol. If symptoms persist after the maximum recommended three doses within a 15-minute period, or if an accidental overdose is suspected, the official protocol dictates the need for prompt medical assessment.


Q: Can Nitroglycerin Streuli be used by women who are pregnant or breastfeeding?

Official labeling states that use during pregnancy is to be considered only if clearly necessary. Furthermore, it is not known if the drug passes into human milk, resulting in cautionary statements regarding use while lactating.


Q: Does alcohol use affect how Nitroglycerin Streuli works?

Yes, regulatory documents mention a constraint regarding alcohol use. Official interaction documents note that consuming alcohol may potentiate the blood-pressure-lowering effect of the medication.


Q: What happens if I miss a dose (if it's a routine-use form)?

The quick-acting forms of Nitroglycerin Streuli are typically intended for intermittent use on an as-needed (p.r.n.) basis for acute relief. Therefore, given its intended intermittent use, the concern about a 'missed dose' is not relevant to this product.


Q: Is Nitroglycerin Streuli only for people with established cardiovascular problems?

The general therapeutic purpose of this product is the rapid relief of acute episodes of angina pectoris (chest pain related to the heart). Official documents also mention its use for acute prophylaxis—taking it preventatively before engaging in activities known to trigger symptoms—which relates to existing coronary artery disease.


Q: Is it possible to feel dizzy after using Nitroglycerin Streuli?

Yes, official labeling lists certain effects related to the medicine's action as a vasodilator. Dizziness and hypotension (low blood pressure) are documented as common adverse reactions associated with the product.


Q: Is Nitroglycerin Streuli the same as nitroglycerin used for other conditions?

Nitroglycerin Streuli is a specific brand formulation containing the active ingredient Glyceryl Trinitrate (GTN), also known as Nitroglycerin. The active ingredient itself is used in various formulations (e.g., patches, slow-release tablets) to address different cardiovascular needs, but this specific product is for rapid, acute relief.


Q: Is it true that Nitroglycerin Streuli lowers blood pressure?

The drug's mechanism involves widespread vasodilation, or the widening of blood vessels. This action alters blood flow and is intended to decrease the heart's workload, which can also result in hypotension (low blood pressure) as a common adverse effect.


Q: How long does the effect of Nitroglycerin Streuli typically last?

Pharmacokinetic research notes that the mean elimination half-life of the major active metabolites is approximately 40 minutes following administration of the quick-acting form. This describes the time required for the amount of drug in the body to be reduced by half.


Q: What's the difference between Nitroglycerin Streuli and other common chest pain medications?

Nitroglycerin Streuli is categorized as a rapid-acting organic nitrate and functions as a powerful vasodilator. Its purpose is specifically for the immediate relief of acute symptoms, rather than long-term maintenance treatment.


Q: Can older people use Nitroglycerin Streuli?

Regulatory documents indicate that use in older adults is permitted. However, cautious dose selection is often considered, potentially starting at the lower end of the approved range, due to common age-related changes.


Q: Does having liver or kidney problems change how Nitroglycerin Streuli is used?

Regulatory information indicates that reduced renal (kidney) or hepatic (liver) function may be a consideration, especially in older adults. If these conditions are present, cautious dose selection may be a consideration.


Q: What does it mean if the medicine doesn't seem to work as quickly as before?

Official product information and regulatory documents discuss the potential for tolerance to develop with repeated or continuous use. Studies have examined the potential for this to lead to reduced effectiveness over time. Impaired dissolution due to dry mouth caused by other medications may also be a factor.


Q: Is it normal to feel a tingling sensation after taking Nitroglycerin Streuli?

While not listed as a common official adverse effect in all regulatory summaries, some official patient information sources note that a tingling or burning feeling in the mouth may sometimes be experienced.


Q: Can Nitroglycerin Streuli be used to prevent an issue from happening?

Yes. Official documents confirm that the medicine is used for acute prophylaxis. This means it can be taken preventatively immediately before engaging in activities that a person knows reliably trigger anginal symptoms.


Q: How does the dosage or strength of Nitroglycerin Streuli relate to its effectiveness?

Pharmacological actions are officially described as occurring in a dose-related manner. This means the degree of physiological effect, such as the dilation of blood vessels, is linked to the strength and quantity of the administered dose.


Q: Can taking Nitroglycerin Streuli affect how other common medications work?

Yes. The regulatory profile indicates that nitroglycerin may cause additive hypotensive effects when taken with many antihypertensive medicines. It can also alter the breakdown of certain other medications, potentially increasing their effects in the body.


Q: Is Nitroglycerin Streuli a prescription-only medicine?

Yes. Regulatory texts in many regions classify this medication as a Prescription-Only Medicine (Rx). This classification reflects the serious nature of the conditions it is designed to manage.


Q: Are there different brand names for the same Nitroglycerin Streuli ingredient?

Yes. The active ingredient in Nitroglycerin Streuli is Glyceryl Trinitrate (GTN), which is also commonly referred to as Nitroglycerin. This active substance is available under various brand names globally.


Q: Can a person develop resistance to Nitroglycerin Streuli over time?

Regulatory documents and systematic reviews of the research have examined the potential for a state known as tolerance to develop with repeated or continuous use of organic nitrates.


Q: Are there any dietary restrictions that official sources mention for Nitroglycerin Streuli?

Official interaction documents only cite a restriction regarding the consumption of alcohol, noting that it may potentiate the blood-pressure-lowering effect. No general food restrictions are routinely cited in regulatory labels.


Q: Do different formulations of Nitroglycerin Streuli (like spray vs. tablet) work differently?

Regulatory documents describe the tablet as administered sublingually (under the tongue) and the spray as translingually (on or under the tongue). Both routes are chosen to allow for rapid absorption by bypassing the liver's initial metabolism.


Q: What does the research say about long-term use of Nitroglycerin Streuli?

Systematic reviews of the research evidence have examined the relationship between use and long-term symptom progression. These studies have examined the relationship between use and changes in the frequency of anginal attacks and exercise capacity over time, along with evaluating long-term tolerability.


Q: Can children ever use Nitroglycerin Streuli?

Regulatory authorities have stated that the safety and effectiveness have not been established in pediatric patients. Therefore, use is generally not recommended in this age group.


Q: Is Nitroglycerin Streuli the kind of medicine you only take when you need it?

Yes. Official documents confirm that the quick-acting products are intended for intermittent use on an as-needed (p.r.n.) basis. Their purpose is the acute relief and prophylaxis of angina pectoris.


Q: What are the signs of a serious allergic reaction to Nitroglycerin Streuli?

Official product information lists known hypersensitivity to nitrates as a formal contraindication for use. In cases of a suspected severe reaction, the official protocol dictates the need for prompt medical assessment.

How should Nitroglycerin Streuli be stored and disposed of?

Storage and Disposal Requirements

Scope Item Official Regulatory Requirement
Labeled storage temperature requirements Store at Controlled Room Temperature (20 C to 25 C / 68 F to 77 F).
Light/moisture protection requirements Protect from moisture and excessive heat; Do not freeze.
Handling requirements The container must be kept tightly closed to prevent loss of potency.
Packaging-related storage rules Must be kept in the original glass container or packaging to maintain stability.
Child-protection storage requirements Must be kept out of the sight and reach of children.
Disposal instructions Dispose of unused or expired product according to local regulations.

Official storage and disposal statements:

  • The product must be kept in the original container and tightly closed to protect it from moisture and volatility.
  • Storage must occur at Controlled Room Temperature, avoiding freezing and excessive heat.
  • Unused medication must be disposed of according to local pharmaceutical waste regulations and should not be flushed unless advised by an official program.
  • Regulatory labeling mandates the product be kept out of the sight and reach of children.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nitroglycerin Streuli found in:

A-Z Index: